BioCatalyst

CHM-2101 CAR-T cells — catalyst calendar

1 verified catalyst event(s) referencing CHM-2101 CAR-T cells, each linked to its official source. Verified as of 2026-10-23.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 2mo
ESTIMATED
 READOUT
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antig
Phase 1/2 · Neuroendocrine Tumors, Colorectal Cancer
 Chimeric Therapeutics CHM-2101 CAR-T cells ClinicalTrials.gov ↗
✓ Source-checked 2026-10-23
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.